CHICAGO — In patients being treated for hypertension, those taking a GLP-1 receptor agonist had higher rates of hypotensive events compared with those not taking one, researchers reported at ENDO 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results